Dana Lasko

Title: Dana Lasko - Innovator in Neurodegenerative Disease Treatment

Introduction

Dana Lasko is a notable inventor based in Montréal, Canada. He has made significant contributions to the field of neurodegenerative diseases, particularly in the treatment of macular degeneration. His innovative work has led to the development of therapeutic compositions that aim to repair and regenerate damaged neural tissues.

Latest Patents

Dana Lasko holds 1 patent for his invention titled "Treatment of macular degeneration with ADP-ribosyl transferase fusion protein therapeutic compositions." This invention focuses on the Rho family GTPases, which play a crucial role in regulating axon growth and regeneration. The patent describes how inactivation of Rho with C3, a toxin, can stimulate regeneration and sprouting of injured axons. The novel chimeric C3-like Rho antagonists provided in this invention promote repair when applied to the injured mammalian central nervous system, such as the retina. Furthermore, the invention outlines methods for treating macular degeneration, inhibiting subretinal neovascularization, and protecting retinal photoreceptor cells from death.

Career Highlights

Dana Lasko is associated with Bioaxone Therapeutique Inc., where he continues to advance his research and development efforts. His work is pivotal in addressing the challenges posed by neurodegenerative diseases, particularly those affecting vision.

Collaborations

Dana collaborates with Lisa McKerracher, a fellow researcher in the field. Their combined expertise enhances the potential for breakthroughs in neurodegenerative disease treatments.

Conclusion

Dana Lasko's innovative contributions to the treatment of macular degeneration highlight the importance of research in neurodegenerative diseases. His work not only advances scientific understanding but also offers hope for effective therapies in the future.